PPT-Medicines Transparency Alliance

Presented by Deirdre Dimancesco Department of Essential Medicines and H ealth Products WHO at the Technical Briefing Seminar 15 April 2013 MeTA aim MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data valid analysis and then disclosure for advocacy and policy dialogue among stakeholders. eaasmeu Counterfeiting the Counterfeiter brPage 2br European Alliance for Access to Safe Medicines Forewords Jim Thomson In 2008 the European Alliance for Access to Safe Medicines EAASM investigative report The Counterfeiting Superhighway exposed th 57345337 57367837157345257345573692 4A757345F4857345B95734594F Alliance for Safe Online Pharmacy Alliance for Safe Online Pharmacy Alliance for Safe Online Pharmacy brPage 2br T085734 March 2016. The background. Born of frustration about :. Inaccurate, misleading or confusing information in public . domain (poor reporting). Lack of information in public domain. A sense we could do . Presented by . Deirdre Dimancesco. Department of Essential Medicines and . H. ealth Products, WHO. at the . Technical Briefing Seminar. 15 April, 2013 . MeTA. aim. MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and policy dialogue among stakeholders.. . mechanisms. in . the. . extractive. industries: . the. cases of Bolivia, Ecuador and Perú. Carlos Casas . Tragodara. Universidad del Pacífico. Lima-Perú. Motivation. In . recent. . years. . Module | Lesson Two. Lesson Two| Introduction. Lesson Overview. The role of transparency and disclosure in CSR activities. Guidelines for transparency and disclosure. Regulators and regulations about transparency and disclosure. Agreement. Achala Abeysinghe. Initial presentation based on the draft paper on ‘Transparency of Action and Support under the Paris Agreement’ by . Harro van Asselt, Romain Weikmans, Timmons Roberts, Achala Abeysinghe. A discussion and a case study of the EU Accounting and Transparency Directives. Niels. . Johannesen. , Associate Professor . Dan Thor Larsen, . M.Sc. Candidate in Economics. Department of Economics. → Educational webinar for GTA partners Sven Biermann, FiTI International Secretariat 12 May 2021 | Zoom Fisheries Transparency Initiative (FiTI), 2021 Focus of today’s webinar 2 Fisheries Transpa We are committed to transparency We bear full responsibility for our actions at all times. Transparency is an essential prerequisite for this. We provide our external stakeholders with information the Report from the Technical Committee of the International Organization of Securities Commissions November 2001 1 Transparency and Market Fragmentation Executive summary Market transparency is general Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . Spirit of the RTI Law . Easy access of citizens to all information . Bureaucracy mandated by Law to provide information . Independent Commissions to not be “neutral”, but play their mandated role of ensuring that all custodians of information provide it to people not just on demand but also proactively . Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...